Skip to main navigation Skip to search Skip to main content

Chest wall pain and rib fracture after stereotactic radiotherapy for peripheral non-small cell lung cancer

  • Jon Paul J. Voroney
  • , Andrew Hope
  • , Max R. Dahele
  • , Thomas Purdy
  • , Kevin N. Franks
  • , Shannon Pearson
  • , John B.C. Cho
  • , Alex Sun
  • , David G. Payne
  • , Jean Pierre Bissonnette
  • , Andrea Bezjak
  • , Anthony M. Brade
  • Alberta Health Services
  • University of Toronto

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Stereotactic body radiotherapy is an emerging treatment option for peripheral non-small cell lung cancer in medically inoperable patients. With high dose per fraction radiotherapy, late side effects are of possible concern. In our initial cohort of 42 patients treated with 54 to 60 Gy in three fractions, nine patients have rib fracture. The median dose to rib fracture sites was 46 to 50 Gy, depending on the method of dose calculation. We describe a typical case of poststereotactic radiotherapy rib fracture and present dosimetric analysis of patients with rib fracture.

Original languageEnglish
Pages (from-to)1035-1037
Number of pages3
JournalJournal of thoracic oncology
Volume4
Issue number8
DOIs
Publication statusPublished - Aug 2009

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Non-small cell lung cancer
  • Rib fracture
  • Stereotactic body radiotherapy

Fingerprint

Dive into the research topics of 'Chest wall pain and rib fracture after stereotactic radiotherapy for peripheral non-small cell lung cancer'. Together they form a unique fingerprint.

Cite this